Generex Biotechnology Corporation has announced the details of an upcoming conference call it will host featuring members of the Antigen Express, Inc. Scientific Advisory Board. The call will take place Wednesday, Aug. 14 at 10 a.m. EDT. Call-in information will be announced prior to the conference call.
Included among members of the Antigen Express Scientific Advisory Board who will be acting as panelists on the call will be: Dr. Gary H. Lyman, M.D., M.P.H., FACP, FRCP (Edin), FASCO; Dr. Gabriel N. Hortobagyi, M.D., FACP; Dr. Ian Krop, M.D., Ph.D.; Dr. Keith L. Knutson, Ph.D.; Dr. James J. Mule, Ph.D.; Dr. Hope S. Rugo, M.D.; Dr. Samuel Jacobs, M.D.; and Dr. Elizabeth Mittendorf, M.D., Ph.D.
The call will cover various topics, including: highlights from the company's June 2013 Annual Meeting of the American Society of Clinical Oncology (ASCO); an update on the ongoing Phase II clinical trial of the AE37 breast cancer vaccine; the current state of breast cancer treatment and treatment trends; treatment options for patients who express low levels of HER2; a review of antibodies and vaccines in immunotherapy, and the importance of CD4+ T cell activation by li-Key; biomarkers and personalized medicine in cancer care and opportunities for the li-Key platform; treatment options for triple-negative breast cancer; and an update from the National Surgical Adjuvant Breast and Bowel Project (NSABP) and the potential for AE37.
Generex is a biotechnology company focused on researching, developing, and commercializing drug delivery systems and technologies. The company has developed a proprietary platform technology for delivering drugs into the human body through the oral cavity (with no deposit in the lungs). Using the company's RapidMist device, its proprietary liquid formulations allow drugs that are typically administered by injection to be absorbed into the body by the inner mouth lining.
For more information about Generex, visit generex.com
Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net